Models for describing absorption rate and estimating extent of bioavailability: Application to cefetamet pivoxil Nicholas H. G. HolfordReinhard J. AmbrosKlaus Stoeckel OriginalPaper 01 October 1992 Pages: 421 - 442
Variational analysis of the transdermal delivery rate from two prototypical ethanol-water nitroglycerin TTS devices and Transderm-Nitro 10 in the normal population Gregory M. KochakBret BernerNancy C. Sambol OriginalPaper 01 October 1992 Pages: 443 - 459
Salbutamol disposition and dynamics in conscious rabbits: Influence of the route of administration and of the dose Sylvie PerreaultHuy OngPatrick du Souich OriginalPaper 01 October 1992 Pages: 461 - 476
Fundamental pharmacokinetic limits on the utility of using a sinusoidal drug delivery system to enhance therapy Ronald R. Burnette OriginalPaper 01 October 1992 Pages: 477 - 500
Bias and variance of extrapolated tails for area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC) Robert D. Purves OriginalPaper 01 October 1992 Pages: 501 - 510
Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects Jaap W. MandemaDavide VerottaLewis B. Sheiner OriginalPaper 01 October 1992 Pages: 511 - 528
Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine Marie DavidianA. Ronald Gallant OriginalPaper 01 October 1992 Pages: 529 - 556
Sample size determination for bioequivalence assessment using a multiplicative model Dieter HauschkeVolker W. SteinijansMartin Burke Short Communication 01 October 1992 Pages: 557 - 561